Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2022. Kindly acknowledge receipt of the same.
07-07-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF) , has purchased 1228 equity shares aggregating to Rs. 92621.71 from 21.06.2022 to 29.06.2022, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta and Sons-HUF. Please acknowledge and take the same on record.
01-07-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the 'Trading Window' for dealing/trading in the shares of the Company shall remain closed from July 01, 2022, till the completion of 48 hours after the declaration of the financial results of the Company, for the first quarter ended June 30, 2022. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time. Kindly take the information on record.
30-06-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Submission Of Consolidated Related Party Transactions As On March 31, 2022.

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find disclosure of Related Party Transactions on consolidated basis for the half year ended March 31, 2022. Kindly take the information on record.
14-06-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that our Registrar & Transfer Agent (RTA), Link Intime India Pvt. Ltd. has received a request letter from Mr. Abraham Mathew Manthara , shareholder, regarding loss of share certificate and request for issue of duplicate thereof. A copy of the email intimation received from our RTA on 09/06/2022 is enclosed herewith. Kindly note that our RTA has initiated process for issuance of duplicate share certificates in lieu thereof subject to compliance of the required formalities. You are requested to take note of the aforesaid information.
10-06-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copies of newspaper cuttings of the extract of Statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2022, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated June 01, 2022. Please acknowledge receipt.
02-06-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on May 30, 2022, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended March 31, 2022. Enclosed please find the Statement as per the format, giving details of the same. Kindly take the information on records.
30-05-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On May 30, 2022

The meeting of the Board of Directors of the Company was held on May 30, 2022, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and year ended March 31, 2022, together with Auditors'' Report . 2. Consolidated Financial Results for the quarter and year ended March 31, 2022, along with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2022, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The Board of Directors'' Meeting started at 5:00 P.M. and ended at 7:20 P.M., on the same day.
30-05-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to circular no. CIR/CFD/CMD1/27/2019 dated February 08, 2019, issued by the Securities and Exchange Board of India, for the purpose of compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the Annual Secretarial Compliance Report for the year ended March 31, 2022, issued by Ms. Girija Nagvekar, Practicing Company Secretary and Secretarial Auditor of the Company. Kindly take the above information on record.
30-05-2022
Next Page
Close

Let's Open Free Demat Account